Sign In
Buy AMPL
$6.66
+0.200 (+3.10%)
At Close: Jun 23, 2026
AMPL Investors Have Opportunity to Join Amplitude, Inc. Fraud Investigation with the Schall Law Firm
12:00pm, Thursday, 11'th Jun 2026
LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Amplitude, Inc. ("Am
Amplitude's Co-Founder and Chief Technology Officer Sold Over 22,000 Company Shares. Here's What That Means for Investors.
01:59pm, Monday, 08'th Jun 2026
CTO Curtis Liu sold 22,201 shares for a transaction value of approximately $178,000 on June 1, 2026, at around $8.03 per share. The sale represented 2.16% of Curtis Liu's direct holdings at the time.
AMPL Investors Have Opportunity to Join Amplitude, Inc. Fraud Investigation with the Schall Law Firm
09:06am, Monday, 08'th Jun 2026
LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Amplitude, Inc. ("Amp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amplitude, Inc. - AMPL
10:00am, Thursday, 04'th Jun 2026
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. ("Amplitude" or the "Company") (NASDAQ: AMPL). Such investors are advised to cont
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amplitude, Inc. - AMPL
05:09pm, Tuesday, 02'nd Jun 2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL). Such investors are
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amplitude, Inc. - AMPL
10:38am, Thursday, 28'th May 2026
NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. ("Amplitude" or the "Company") (NASDAQ: AMPL). Such investors are advised to co
2026 CPO Insights Report Predicts Product Managers Will Disappear by 2030
09:00am, Wednesday, 27'th May 2026
A global survey of 1,500+ Chief Product Officers offers data on the future of product leadership and how organizations can create and deliver value at the speed of AI. SAN FRANCISCO, May 27, 2026 /PRN
AMPL Investors Have Opportunity to Join Amplitude, Inc. Fraud Investigation with the Schall Law Firm
02:00am, Wednesday, 27'th May 2026
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Amplitude,
AMPL Investors Have Opportunity to Join Amplitude, Inc. Fraud Investigation with the Schall Law Firm
01:00am, Wednesday, 27'th May 2026
LOS ANGELES--(BUSINESS WIRE)---- $AMPL--AMPL Investors Have Opportunity to Join Amplitude, Inc. Fraud Investigation with the Schall Law Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amplitude, Inc. - AMPL
05:32pm, Tuesday, 26'th May 2026
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL). Such investors are a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amplitude, Inc. - AMPL
03:25pm, Thursday, 21'st May 2026
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. ("Amplitude" or the "Company") (NASDAQ: AMPL). Such investors are advised to cont
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amplitude, Inc. - AMPL
05:22pm, Tuesday, 19'th May 2026
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL). Such investors are a
BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem
05:30am, Tuesday, 19'th May 2026
CHARLEVOIX, Mich.--(BUSINESS WIRE)--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (A
VVX or AMPL: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 14'th May 2026
Investors interested in stocks from the Technology Services sector have probably already heard of V2X (VVX) and Amplitude, Inc. (AMPL). But which of these two stocks is more attractive to value invest
Amplitude CFO Touts Statsig Deal, AI Agents as Growth Engines
04:10pm, Tuesday, 12'th May 2026
Amplitude NASDAQ: AMPL Chief Financial Officer Andrew Casey outlined the company's platform strategy, its agreement involving Statsig assets and customers, and its push into AI-enabled product develop
